Cargando…

α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb

Alpha-synuclein inclusions, the hallmarks of synucleinopathies, are suggested to spread along neuronal connections in a stereotypical pattern in the brains of patients. Ample evidence now supports that pathological forms of alpha-synuclein propagate in cell culture models and in vivo in a prion-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Rey, Nolwen L., Bousset, Luc, George, Sonia, Madaj, Zachary, Meyerdirk, Lindsay, Schulz, Emily, Steiner, Jennifer A., Melki, Ronald, Brundin, Patrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937797/
https://www.ncbi.nlm.nih.gov/pubmed/31888771
http://dx.doi.org/10.1186/s40478-019-0859-3
_version_ 1783483937613414400
author Rey, Nolwen L.
Bousset, Luc
George, Sonia
Madaj, Zachary
Meyerdirk, Lindsay
Schulz, Emily
Steiner, Jennifer A.
Melki, Ronald
Brundin, Patrik
author_facet Rey, Nolwen L.
Bousset, Luc
George, Sonia
Madaj, Zachary
Meyerdirk, Lindsay
Schulz, Emily
Steiner, Jennifer A.
Melki, Ronald
Brundin, Patrik
author_sort Rey, Nolwen L.
collection PubMed
description Alpha-synuclein inclusions, the hallmarks of synucleinopathies, are suggested to spread along neuronal connections in a stereotypical pattern in the brains of patients. Ample evidence now supports that pathological forms of alpha-synuclein propagate in cell culture models and in vivo in a prion-like manner. However, it is still not known why the same pathological protein targets different cell populations, propagates with different kinetics and leads to a variety of diseases (synucleinopathies) with distinct clinical features. The aggregation of the protein alpha-synuclein yields different conformational polymorphs called strains. These strains exhibit distinct biochemical, physical and structural features they are able to imprint to newly recruited alpha-synuclein. This had led to the view that the clinical heterogeneity observed in synucleinopathies might be due to distinct pathological alpha-synuclein strains. To investigate the pathological effects of alpha-synuclein strains in vivo, we injected five different pure strains we generated de novo (fibrils, ribbons, fibrils-65, fibrils-91, fibrils-110) into the olfactory bulb of wild-type female mice. We demonstrate that they seed and propagate pathology throughout the olfactory network within the brain to different extents. We show strain-dependent inclusions formation in neurites or cell bodies. We detect thioflavin S-positive inclusions indicating the presence of mature amyloid aggregates. In conclusion, alpha-synuclein strains seed the aggregation of their cellular counterparts to different extents and spread differentially within the central nervous system yielding distinct propagation patterns. We provide here the proof-of-concept that the conformation adopted by alpha-synuclein assemblies determines their ability to amplify and propagate in the brain in vivo. Our observations support the view that alpha-synuclein polymorphs may underlie different propagation patterns within human brains.
format Online
Article
Text
id pubmed-6937797
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69377972019-12-31 α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb Rey, Nolwen L. Bousset, Luc George, Sonia Madaj, Zachary Meyerdirk, Lindsay Schulz, Emily Steiner, Jennifer A. Melki, Ronald Brundin, Patrik Acta Neuropathol Commun Research Alpha-synuclein inclusions, the hallmarks of synucleinopathies, are suggested to spread along neuronal connections in a stereotypical pattern in the brains of patients. Ample evidence now supports that pathological forms of alpha-synuclein propagate in cell culture models and in vivo in a prion-like manner. However, it is still not known why the same pathological protein targets different cell populations, propagates with different kinetics and leads to a variety of diseases (synucleinopathies) with distinct clinical features. The aggregation of the protein alpha-synuclein yields different conformational polymorphs called strains. These strains exhibit distinct biochemical, physical and structural features they are able to imprint to newly recruited alpha-synuclein. This had led to the view that the clinical heterogeneity observed in synucleinopathies might be due to distinct pathological alpha-synuclein strains. To investigate the pathological effects of alpha-synuclein strains in vivo, we injected five different pure strains we generated de novo (fibrils, ribbons, fibrils-65, fibrils-91, fibrils-110) into the olfactory bulb of wild-type female mice. We demonstrate that they seed and propagate pathology throughout the olfactory network within the brain to different extents. We show strain-dependent inclusions formation in neurites or cell bodies. We detect thioflavin S-positive inclusions indicating the presence of mature amyloid aggregates. In conclusion, alpha-synuclein strains seed the aggregation of their cellular counterparts to different extents and spread differentially within the central nervous system yielding distinct propagation patterns. We provide here the proof-of-concept that the conformation adopted by alpha-synuclein assemblies determines their ability to amplify and propagate in the brain in vivo. Our observations support the view that alpha-synuclein polymorphs may underlie different propagation patterns within human brains. BioMed Central 2019-12-30 /pmc/articles/PMC6937797/ /pubmed/31888771 http://dx.doi.org/10.1186/s40478-019-0859-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Rey, Nolwen L.
Bousset, Luc
George, Sonia
Madaj, Zachary
Meyerdirk, Lindsay
Schulz, Emily
Steiner, Jennifer A.
Melki, Ronald
Brundin, Patrik
α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb
title α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb
title_full α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb
title_fullStr α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb
title_full_unstemmed α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb
title_short α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb
title_sort α-synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937797/
https://www.ncbi.nlm.nih.gov/pubmed/31888771
http://dx.doi.org/10.1186/s40478-019-0859-3
work_keys_str_mv AT reynolwenl asynucleinconformationalstrainsspreadseedandtargetneuronalcellsdifferentiallyafterinjectionintotheolfactorybulb
AT boussetluc asynucleinconformationalstrainsspreadseedandtargetneuronalcellsdifferentiallyafterinjectionintotheolfactorybulb
AT georgesonia asynucleinconformationalstrainsspreadseedandtargetneuronalcellsdifferentiallyafterinjectionintotheolfactorybulb
AT madajzachary asynucleinconformationalstrainsspreadseedandtargetneuronalcellsdifferentiallyafterinjectionintotheolfactorybulb
AT meyerdirklindsay asynucleinconformationalstrainsspreadseedandtargetneuronalcellsdifferentiallyafterinjectionintotheolfactorybulb
AT schulzemily asynucleinconformationalstrainsspreadseedandtargetneuronalcellsdifferentiallyafterinjectionintotheolfactorybulb
AT steinerjennifera asynucleinconformationalstrainsspreadseedandtargetneuronalcellsdifferentiallyafterinjectionintotheolfactorybulb
AT melkironald asynucleinconformationalstrainsspreadseedandtargetneuronalcellsdifferentiallyafterinjectionintotheolfactorybulb
AT brundinpatrik asynucleinconformationalstrainsspreadseedandtargetneuronalcellsdifferentiallyafterinjectionintotheolfactorybulb